These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15548712)

  • 1. Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines.
    Ito F; Li Q; Shreiner AB; Okuyama R; Jure-Kunkel MN; Teitz-Tennenbaum S; Chang AE
    Cancer Res; 2004 Nov; 64(22):8411-9. PubMed ID: 15548712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137.
    Yang S; Yang Y; Raycraft J; Zhang H; Kanan S; Guo Y; Ronai Z; Hellstrom I; Hellstrom KE
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4990-5. PubMed ID: 15051893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response.
    Delluc S; Hachem P; Rusakiewicz S; Gaston A; Marchiol-Fournigault C; Tourneur L; Babchia N; Fradelizi D; Regnault A; Sang KH; Chiocchia G; Buzyn A
    Cancer Immunol Immunother; 2009 Oct; 58(10):1669-77. PubMed ID: 19225777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy.
    Kühnöl C; Herbarth M; Föll J; Staege MS; Kramm C
    Cancer Immunol Immunother; 2013 Dec; 62(12):1797-809. PubMed ID: 24129764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-lymphoma activities of anti-CD137 monoclonal antibodies are enhanced in FcγRIII(-/-) mice.
    Sallin MA; Zhang X; So EC; Burch E; Cai L; Lin W; Chapoval AI; Strome SE
    Cancer Immunol Immunother; 2014 Sep; 63(9):947-58. PubMed ID: 24927849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection.
    Lee SC; Ju SA; Pack HN; Heo SK; Suh JH; Park SM; Choi BK; Kwon BS; Kim BS
    Infect Immun; 2005 Aug; 73(8):5144-51. PubMed ID: 16041031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD27 Antibody Potentiates Antitumor Effect of Dendritic Cell-Based Vaccine in Prostate Cancer-Bearing Mice.
    Wei SM; Fei JX; Tao F; Pan HL; Shen Q; Wang L; Wu YJ; Zhou L; Zhu SX; Liao WB; Ji H; Xin ZL
    Int Surg; 2015 Jan; 100(1):155-63. PubMed ID: 25594656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells.
    Matson AW; Hullsiek RH; Dixon KJ; Wang S; Lindstedt AJ; Friess RR; Phung SK; Freedman TS; Felices M; Truckenbrod EN; Wu J; Miller JS; Walcheck B
    bioRxiv; 2024 May; ():. PubMed ID: 38798522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering CaP-Pickering emulsion for enhanced mRNA cancer vaccines via dual DC and NK activations.
    Wu S; Zhou Y; Asakawa N; Wen M; Sun Y; Ming Y; Song T; Chen W; Ma G; Xia Y
    J Control Release; 2024 Sep; 373():837-852. PubMed ID: 39059499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells" [Neoplasia 39 (2023), 100893].
    Shui Y; Hu X; Hirano H; Tsukamoto H; Guo WZ; Hasumi K; Ijima F; Fujino M; Li XK
    Neoplasia; 2024 Sep; 55():101018. PubMed ID: 38943994
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunostimulatory monoclonal antibodies for cancer therapy.
    Melero I; Hervas-Stubbs S; Glennie M; Pardoll DM; Chen L
    Nat Rev Cancer; 2007 Feb; 7(2):95-106. PubMed ID: 17251916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell costimulation with anti-CD137 monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes.
    Martinez-Forero I; Azpilikueta A; Bolaños-Mateo E; Nistal-Villan E; Palazon A; Teijeira A; Perez-Chacon G; Morales-Kastresana A; Murillo O; Jure-Kunkel M; Zapata JM; Melero I
    J Immunol; 2013 Jun; 190(12):6694-706. PubMed ID: 23690480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.
    Hirano F; Kaneko K; Tamura H; Dong H; Wang S; Ichikawa M; Rietz C; Flies DB; Lau JS; Zhu G; Tamada K; Chen L
    Cancer Res; 2005 Feb; 65(3):1089-96. PubMed ID: 15705911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer.
    Gao X; Yi L; Jiang C; Li S; Wang X; Yang B; Li W; Che N; Wang J; Zhang H; Zhang S
    Front Immunol; 2023; 14():1142428. PubMed ID: 37025995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.
    Hamid O; Chiappori AA; Thompson JA; Doi T; Hu-Lieskovan S; Eskens FALM; Ros W; Diab A; Spano JP; Rizvi NA; Wasser JS; Angevin E; Ott PA; Forgie A; Yang W; Guo C; Chou J; El-Khoueiry AB
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36302562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.
    Knitz MW; Bickett TE; Darragh LB; Oweida AJ; Bhatia S; Van Court B; Bhuvane S; Piper M; Gadwa J; Mueller AC; Nguyen D; Nangia V; Osborne DG; Bai X; Ferrara SE; Boss MK; Goodspeed A; Burchill MA; Tamburini BAJ; Chan ED; Pickering CR; Clambey ET; Karam SD
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD137
    Ugolini A; Nuti M
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma.
    Cesarini V; Scopa C; Silvestris DA; Scafidi A; Petrera V; Del Baldo G; Gallo A
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32957732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.
    Hong JP; McCarthy MK; Davenport BJ; Morrison TE; Diamond MS
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer.
    Chu DT; Bac ND; Nguyen KH; Tien NLB; Thanh VV; Nga VT; Ngoc VTN; Anh Dao DT; Hoan LN; Hung NP; Trung Thu NT; Pham VH; Vu LN; Pham TAV; Thimiri Govinda Raj DB
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.